CALENDAR: May 24, 2010

CALENDAR: May 24, 2010
9 a.m. Rivertown Thrift Shop, Rivertown Senior Center, Second and Warren St., Athens. To 2 p.m.
Read more on Kingston Daily Freeman

NKTR-102 Phase 2 Clinical Data Accepted for Oral Presentation at 2010 ASCO Annual Meeting

NKTR-102 Phase 2 Clinical Data Accepted for Oral Presentation at 2010 ASCO Annual Meeting
SAN CARLOS, Calif., May 20 /PRNewswire-FirstCall/ — Nektar Therapeutics (Nasdaq: NKTR) today announced that results from the Phase 2 clinical trial of NKTR-102 in women with platinum-resistant/refractory ovarian cancer will be presented at the Oral Abstract Session of the Gynecologic Cancer Track [...]

CEL-SCI Corporation Reports Second Quarter 2010 Financial Results

CEL-SCI Corporation Reports Second Quarter 2010 Financial Results
VIENNA, Va.—-CEL-SCI Corporation reports financial results for the quarter ended March 31, 2010.
Read more on Business Wire via Yahoo! Finance

CALENDAR: May 17, 2010

CALENDAR: May 17, 2010
9 a.m. Rivertown Thrift Shop, Rivertown Senior Center, Second and Warren St., Athens. To 2 p.m.
Read more on Kingston Daily Freeman

Business people – May 16, 2010

Business people – May 16, 2010
Starion Financial has hired Jaylene Axtman as a credit administration project analyst in its downtown Bismarck location.
Read more on The Bismarck Tribune

Transition Therapeutics Announces Third Quarter Fiscal 2010 Financial Results

Transition Therapeutics Announces Third Quarter Fiscal 2010 Financial Results
TORONTO — Transition Therapeutics Inc. , a product-focused biopharmaceutical company developing therapeutics for disease indications with large markets, today announced its financial results for the quarter ended March 31, 2010.
Read more on GlobeNewswire via Yahoo! Finance

Immunomedics Announces Third Quarter Fiscal 2010 Results and Clinical Program Developments

Immunomedics Announces Third Quarter Fiscal 2010 Results and Clinical Program Developments
MORRIS PLAINS, N.J. — Immunomedics, Inc. , a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today reported financial results for the third quarter ended March 31, 2010.
Read more on GlobeNewswire via Yahoo! Finance

NicOx reports first quarter 2010 financial results

NicOx reports first quarter 2010 financial results
SOPHIA ANTIPOLIS, FRANCE–(Marketwire – May 7, 2010) – www.nicox.com — NicOx S.A. (NYSE Euronext Paris: COX) today reported financial results for the first three months of 2010 and provided an overview of its activities, in particular those related to its lead compound naproxcinod which is currently under review by [...]

XOMA Reports First Quarter 2010 Financial Results

XOMA Reports First Quarter 2010 Financial Results
BERKELEY, Calif. — XOMA Ltd. , a leader in the discovery and development of therapeutic antibodies, today announced its financial results for the first quarter of 2010 and provided a general business update.
Read more on GlobeNewswire via Yahoo! Finance

ADDING and REPLACING 2010 BIO International Convention Exhibitor Profiles

ADDING and REPLACING 2010 BIO International Convention Exhibitor Profiles
CHICAGO—-Please note the addition of Archivel Farma S.L., BIO5 Institute, Izon Science, and SOLVO Biotechnology to the list of exhibitor profiles in release dated April 29, 2010.
Read more on Business Wire via Yahoo! Finance

Next Page »